A prize package valued at approximately 50 dollars will be awarded to one of the ventures of the life sciences industry during the "ILSI - Biomed Israel 2008" week, this coming May
In order to encourage excellence in the Israeli biomed industry, the Red Biomed Incubator initiated a national competition to identify the outstanding project among life science industry ventures. One of the conditions for submitting the application is the inventions of the project in the initial stage - Pre-seed. The winning project will receive its first exposure as part of the annual international conference of the life sciences industry "ILSI - Biomed Israel 2008", which will be held this May, and will win a prize package valued at approximately 50 thousand dollars.
The projects that entered the final competition:
1. CLT (Closed Loop Therapies) company - an implanted device for automatic detection and treatment of atrial fibrillation in the heart
2. Lubricant company - joint lubricant to prevent the erosion of cartilage and joint bones, and to prevent the development of an inflammatory degenerative disease
3. Discover medical devices company - an interface to prevent sleep apnea
4. Targia company - repositioning of drugs for the nervous system, among other things by reducing the side effects, by chemically stimulating the vagus nerve
5. NovoGenesis company - technology to replace damaged artery or heart tissue with engineered tissue (development of a natural polymeric skeleton for human transplantation)
6. Prius company - a system for processing and sending medical imaging data (ultrasound) of pregnant women to a medical decoding center that will remotely examine vital parameters for the normality of the fetus
7. Coromedic company - a device for performing bypass surgery through a minimal incision
8. Tavor company - a product that will help shorten the time of surgery to reconstruct a cruciate ligament in the knee, and prevent the formation of inflammations typical of surgery.
The outstanding project will be chosen by a panel of judges, which will consist of members of the ILSI (Israeli Life Sciences Industry Association) management and the sponsors of the competition: Ruthi Alon - senior partner in the venture capital fund Pitango and chairman of ILSI, Dr. Benny Zavi - partner and director of the Tamir Fishman Wentz Fund Ras, Dr. Rafi Hofstein- CEO of Hadasit, Zev Zelig- CEO and Vice President of Genzyme Israel and Chairman of Pharma Israel, Yossi Bornstein- CEO of Shizim, Dr. Orna Oz- Partner and CEO Liit Biomedical Strategies Company, Shervin Pomeranz- CEO of Atid IDA, Benny Sofer- Director of the Business Development Unit at the Technion, Dr. Idan Tamir- CEO of Red Biomed Laboratory, Dr. Ilan Cohen- Senior Partner At the office of patent editors Reinhold Cohen and his partners.
The greenhouse - Red Biomed, will finance the winner of a grant in the amount of 5,000 dollars and in addition will give the winning project an office rent for a year within the greenhouse. The patent drafting office Reinhold Cohen and its partners will provide consultation and patent filing up to the PCT stage (valued at $7,000); The accounting firm Kesselman & Kesselman (PWC) will provide the winner with assistance in writing the business plan, or help in the field of accounting services; Sunrise Projects will assist in writing an application for an R&D grant, and will provide regulatory consulting services (worth $5,000); And a biomedical strategies company will provide consulting and regulatory strategy review, valued at $5,000.
According to Dr. Idan Tamir, director of the Red Biomed Incubator: "We looked for projects with high potential, in order to encourage their transformation into a profitable biomedical industry." Tamir also noted that the announcement and awarding ceremony will take place on Tuesday 27.05.08/17/15, at XNUMX:XNUMX PM, at the David Intercontinental Hotel in Tel Aviv.
The Red Biomed Incubator is a pioneering initiative of the Red Computer Communications Group. It began its journey in Israel in 1992, at the initiative of the brothers Yehuda and Zahar Zisafel and under the auspices of the Office of the Chief Scientist of the Ministry of Commerce and Industry. The company is located in Tel Aviv and focuses on fostering initiatives in various aspects of the life sciences: biotechnology, drug development, medical devices, diagnostics, and drug delivery. There are currently 7 companies in the incubator period operating between its walls: Immunarei, Ricogen, Cytogen, Impedi-Gide, Terazum, Agzyme, and AO Pharma, and 5 more mature companies: Protrac, Maimonidex, Steadimed, Ario Medica and Flexiprove.
"ILSI - Biomed Israel 2008" week is the main event of the life sciences industry. It will be held this year (this is the seventh time) between May 27 and 29 at David Intercontinental and Dan Panorama in Tel Aviv. Biomed week includes an international professional conference starring the best experts, and an exhibition, presenting the hottest medical innovations. This year, on the occasion of the 60th anniversary of the State of Israel, a central stage will be given to 70 Israeli start-up companies, the most advanced in the industry, both in the field of biopharma and in the field of medical devices. At the same time, two other events will be held: the 2nd International Conference on Stem Cell Research, and the ISRACAS 2008 Conference, the 11th Conference on Computer-Based Surgery, Medical Robotics and Medical Imaging. The Israeli Biomed Week is documented to attract, again this year, approximately 6,000 CEOs and executives of Biomed companies, scientists and researchers, managers of venture capital funds and private investors (Angels), from Israel and abroad. Event website: http://www.kenes.com/biomed
